Posted on 11/6/17
ADMA Biologics Provides Corporate Update
RAMSEY, N.J., Nov. 03, 2017 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ:ADMA), a vertically integrated commercial biopharmaceutical and specialty immunoglobulin company that develops, manufactures and markets . . .
Posted on 11/3/17
5 Things Pfizer's Management Just Said That You Don't Want to Miss
Forget Pfizer's (NYSE:PFE) third-quarter earnings announcement. The real story lies in what the company's top executives said afterward.The big pharma company reported its third-quarter results on . . .
Posted on 11/3/17
Lung Cancer Research Foundation Awards $1.6 Million in Research Grants
The Lung Cancer Research Foundation (LCRF) announced the recipients of its 2017 Scientific Grant Program Awards at the Twelfth Annual Lung Cancer Awareness Luncheon, held on . . .
Posted on 11/2/17
Johnson & Johnson (JNJ) Quarterly Report
Posted on 11/2/17
Johnson & Johnson: Not Overvalued Per FCF Standpoint
With the level of growth that Johnson & Johnson (JNJ) has been witnessing this year, it's coming to be one of the last companies you would . . .
Posted on 11/2/17
Pfizer Inc. (PFE) Q3 2017 Earnings Conference Call Transcript
IMAGE SOURCE: THE MOTLEY FOOL.Pfizer Inc. (NYSE:PFE)Q3 2017 Earnings Conference CallOct. 31, 2017, 8:00 a.m. EDTContents:Prepared RemarksQuestions and AnswersCall ParticipantsPrepared Remarks:OperatorGood day, everyone, and welcome to . . .
Posted on 11/2/17
Celgene Prices $3 Billion of Senior Unsecured Notes
SUMMIT, N.J.--(BUSINESS WIRE)--Celgene Corporation (NASDAQ:CELG) today announced the successful pricing of three series of senior unsecured notes for an aggregate principal amount of $3,000 million. Of . . .
Posted on 11/1/17
Pfizer Inc. Q3 Earnings: The Most Important Things to Know
Pfizer's (NYSE:PFE) overall story so far in 2017 has been a mediocre one. The big pharma company's stock is up year to date, but barely half . . .
Posted on 11/1/17
B&G Foods (BGS) Q3 2017 Results - Earnings Call Transcript
B&G Foods, Inc. (NYSE:BGS)Q3 2017 Earnings CallOctober 31, 2017 4:30 pm ETExecutivesBruce C. Wacha - B&G Foods, Inc.Robert C. Cantwell - B&G Foods, Inc.AnalystsRobert Moskow - . . .
Posted on 11/1/17
Pfizer (PFE) Q3 2017 Results - Earnings Call Transcript
Pfizer Inc. (NYSE:PFE)Q3 2017 Earnings CallOctober 31, 2017 10:00 am ETExecutivesCharles E. Triano - Pfizer Inc.Ian C. Read - Pfizer Inc.Frank A. D'Amelio - Pfizer Inc.Albert . . .
Posted on 11/1/17
If Celgene Buys This Biotech, Investors Should Win Big Time
Celgene (NASDAQ:CELG) has fallen on hard times of late -- or its stock has, at least. At the beginning of October, the biotech's share price was . . .
Posted on 11/1/17
Soligenix Prices $5,115,000 Concurrent Registered Direct Offering
Soligenix, Inc. (Nasdaq: SNGX), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced . . .
Posted on 10/31/17
Dividend Aristocrats In Focus Part 27: Johnson & Johnson
Every year, we review each of the 51 Dividend Aristocrats, a group of companies in the S&P 500 Index, with 25+ consecutive years of dividend increases. . . .
Posted on 10/31/17
Celgene (CELG) Presents At ECTRIMS 2017 IR Event - Slideshow
The following slide deck was published by Celgene Corporation in conjunction with this event. 154READ FULL ARTICLE HERE
Posted on 10/31/17
2 Top Pharma Stocks on Sale This Week
Like most investors, I love a good bargain. So when the top pharma stocks Celgene Corporation (NASDAQ:CELG) and GlaxoSmithKline plc (NYSE:GSK) both crashed last week, it . . .
Posted on 10/31/17
Celgene Corporation Has "Optionality and Opportunity"
Celgene (NASDAQ:CELG) got crushed after announcing third-quarter earnings, saying revenue would come in at the bottom of previous guidance, and lowering its 2020 guidance. All things . . .
Posted on 10/31/17
3 Reasons I've Been Aggressively Buying Intercept Pharmaceuticals
I admit it: I love trying to catch a falling knife. Sometimes you get sliced in the process, while at other times you leave vindicated by . . .
Posted on 10/30/17
CVS And Aetna: A Marriage Made In Money Hell
It's no secret that fears over Amazon (NASDAQ:AMZN) breaking into the mail order drug delivery business, and also potentially launching its own pharmacy benefits manager or . . .
Posted on 10/30/17
Merck & Co. (MRK) Q3 2017 Results - Earnings Call Transcript
Merck & Co., Inc. (NYSE:MRK)Q3 2017 Earnings CallOctober 27, 2017 8:00 am ETExecutivesTeri Loxam - Merck & Co., Inc.Kenneth C. Frazier - Merck & Co., Inc.Robert . . .
Posted on 10/30/17
Why Celgene Got Pummeled
Revlimid. Source: drugs.comCelgene (CELG) reported Q3 earnings Thursday and it did not go well. Investors did not like what they heard and pummeled CELG, driving the . . .
Posted on 10/30/17
Stop Panicking About Celgene
Judging by the market reaction to Celgene's (NASDAQ:CELG) third-quarter results, you'd think one of the Four Horsemen of the Apocalypse just rode down Wall Street. Or . . .
Posted on 10/30/17
Celgene At $100: Buy, Sell, or Hold?
It's been a rotten couple of weeks to be a shareholder of Celgene (NASDAQ:CELG). The biotech giant's shares have been in near-freefall after they reached an . . .
Posted on 10/27/17
Should You Be Worried After Bristol-Myers Squibb's Q3 Results?
It's been an up-and-down kind of year for Bristol-Myers Squibb (NYSE:BMY). Early in 2017, investors were concerned after the company opted not to pursue accelerated approval . . .
Posted on 10/27/17
Celgene: Sell-Off Is Overdone
It's never fun when you see one of your holdings sell off ~20% or so in a single trading day. This typically means that something has . . .
Posted on 10/27/17
Celgene Crashes: A Reassessment
IntroductionNow that Celgene (CELG) has plunged in short order from an all-time high above $145 to below $100 as I write this intra-day Thursday, it's time . . .

